FEATURED EDITORIAL
The project established predictability during testing and release for the production of medicine to support clinical trials.
- Restoring Immune Homeostasis As A Development Approach To Treat And Modify Inflammatory Disease
- Keys To Successful CMC Source Document Preparation For Cell & Gene Therapies
- Tracking The Latest Developments In CAR T Safety And Efficacy
- Araris Doubles Down With Dual-payload ADC
- AI Is A Tool — Not A Replacement — For Human Innovation In Drug Discovery
- Does Targeting Macrophages Hold The Key For Treating Cancer?
- Great siRNA Science Or Savvy Business Acumen? You Need Both
FEATURED APPLICATION CONTENT
-
Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.
-
Discover a system that automates mAb purification, reducing time and costs in cell line development while improving reproducibility, with faster processing than traditional methods.
-
Discover a combination that enables efficient clone selection and automated purification, improving bioprocessing speed, and accelerating biotherapeutic development.
-
This study evaluates a cost-effective alternative to Proleukin® for expanding T cells that demonstrates comparable performance across cell viability, subpopulation ratios, and clinical consistency.
-
Explore two innovative technologies that address major purification challenges in DSP: continuous multi-column chromatography and advanced chromatography or liquid chromatography-mass spectrometry.
-
Issues related to cleaning and cleaning validation are some of the most common concerns that arise in FDA Warning Letters. Discover how to ensure you pass your cleaning validation tests.
-
Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.
-
Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.
-
Discover how you can achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.
-
Learn about a rapid, high-throughput method for determining the E/F ratio in the AAV drug product that is well-suited for screening both crude and purified AAV samples.
-
Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.
-
Examine the performance of a biosensor for AAV capsid titer measurement that offers high-precision, broad AAV serotype binding specificity, and more.
FEATURED NEWS HEADLINES
- Modalis Therapeutics Has Received An Orphan Drug Designation From The U.S. Food And Drug Administration For MDL-101, A Treatment For Congenital Muscular Dystrophy Type 1A (LAMA2-CMD).
- SPT Labtech And ICE Bioscience Launch Joint Automated Laboratory In China For Intelligent Drug Screening
- Accelerate Antibody Capture With Sartobind® Rapid A Lab For Fast, Flexible, And Future-Proof Affinity Chromatography
- AI Computer Models May Make Development Of New Drugs Easier And More Cost-Effective
- ViaNautis Bio Signs Strategic Collaboration Agreement With Lilly To leverage Its polyNaut® Platform To Develop Novel Products Delivering Genetic Medicines
- Tyra Biosciences Receives IND Clearance From FDA To Proceed With Phase 2 Study Of TYRA-300 In Pediatric Achondroplasia (BEACH301)
- Odyssey Therapeutics And Terray Therapeutics Enter Strategic Collaboration To Jointly Discover And Develop First-In-Class Transcription Factor Therapies
- Sparrow Pharmaceuticals Announces Completion Of Phase 2 Trial And FDA Orphan Drug Designation Of Clofutriben For Endogenous Cushing's Syndrome
- Discovery Of Critical Iron-Transport Protein In Malaria Parasites Could Lead To Faster-Acting Medications
- Unique Multidomain Enzymes From Bacteria
ARCHIVED NEWSLETTER
- 10.29.24 -- Keys To Successful CMC Source Document Preparation For Cell & Gene Therapies
- 10.22.24 -- Accelerate Bioprocessing In Gene Therapy Using Octet Biolayer Interferometry
- 10.22.24 -- A Look Into 'Mirror Molecules' May Lead To New Medicines
- 10.18.24 -- Resources For Trouble-Free Validation
- 10.16.24 -- Revolutionizing Pharma: Storage, Disaster Recovery, and Nitrosamine Solutions